ArticleBMJ case reports2019

Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.

Min Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.